「is」の検索結果
102件：26～30件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
ide for Glaucoma by nanocrystallization and tyloxapol addition Shuya Masuda 1,2, Shiho Yano 1, Tomohisa Tadokoro 1, Hiroko Otake 1, Noriaki Nagai 1 1 Faculty of Pharmacy, Kindai University 2 Pharmaceu...
http://www.senju.co.jp/english/rd/thesis/ -
Company Profile | About Senju | SENJU Pharmaceutical
Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Milestones in Our History Data And Statistics About Senju Lists About Senju CEO MessageManagem...
http://www.senju.co.jp/english/about/outline.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) Pranoprofeninflammati...
http://www.senju.co.jp/english/rd/pipeline.html -
Senju initiated Phase III Clinical Trials in Japan for “SJP-0132” for the treatment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharma...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322_0.pdf -
研究開発の取り組み | 千寿製薬株式会社
R & D activities R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please chang
http://www.senju.co.jp/english/rd/